IGHE and asthma: Atopic (perennial allergen sensitivity and total IgE level 30–1500 IU/mL) and eosinophilic (blood eosinophil counts ≥150 cells/μL in admission; or ≥300 cells/μL in the previous year) patients with asthma suitable for both biologics were included in the study.